Home › Kidney Failure › NCT06487546
Repletion of Ergothioneine in Patients With Kidney Failure
Recruiting
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * kidney failure receiving hemodialysis or peritoneal dialysis Exclusion Criteria: * blood transfusion within 90 days * taking supplements which contain ergothioneine
About the study
Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals. One potentially valuable chemical called ergothioneine, which comes from the diet, is low in the blood of people receiving dialysis. For this research study, the investigators hope to learn how well a daily ergothioneine supplement will replenish the levels in the blood of people with kidney failure.
What is being tested
- Ergothioneine (dietary supplement)
- Placebo (other)
Sponsor: Stanford University · Participants: 28 · Started: Apr 1, 2025
Contact the study team
- Tammy Sirich, MD · Phone: 650-493-5000
Official record on ClinicalTrials.gov — NCT06487546
Locations in the U.S.
| California | Veterans Affairs Palo Alto, Palo Alto |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.